These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6160247)

  • 1. Bleomycin-induced scleroderma.
    Finch WR; Rodnan GP; Buckingham RB; Prince RK; Winkelstein A
    J Rheumatol; 1980; 7(5):651-9. PubMed ID: 6160247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.
    Buckingham RB; Prince RK; Rodnan GP
    J Lab Clin Med; 1983 May; 101(5):659-69. PubMed ID: 6833837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD40-CD154 interaction in tissue fibrosis.
    Kawai M; Masuda A; Kuwana M
    Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.
    Liu S; Kapoor M; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma in association with the use of bleomycin: a report of 3 cases.
    Kerr LD; Spiera H
    J Rheumatol; 1992 Feb; 19(2):294-6. PubMed ID: 1378497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.
    Yamamoto T; Nishioka K
    Exp Dermatol; 2005 Feb; 14(2):81-95. PubMed ID: 15679577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
    Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
    Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
    Yamamoto T; Katayama I; Nishioka K
    J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
    Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
    Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
    Yamamoto T; Takagawa S; Katayama I; Nishioka K
    Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bleomycin-induced PSS-like pseudoscleroderma. Case report and review of the literature].
    Behrens S; Reuther T; von Kobyletzki G; Kastner U; Dirschka T; Kerscher M; Altmeyer P
    Hautarzt; 1998 Sep; 49(9):725-9. PubMed ID: 9794163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin-induced scleroderma.
    Sharma SK; Handa R; Sood R; Aggarwal P; Biswas A; Kumar U; Wali JP
    J Assoc Physicians India; 2004 Jan; 52():76-7. PubMed ID: 15633728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Symptomatic scleroderma caused by bleomycin].
    Bork K; Korting GW
    Hautarzt; 1983 Jan; 34(1):10-2. PubMed ID: 6188716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet.
    Lakos G; Melichian D; Wu M; Varga J
    Pathobiology; 2006; 73(5):224-37. PubMed ID: 17314493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.